http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010116016-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34223367a94156ef1751640cb34fe46f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3de7c68cfbf3e9664ade0f0a6a95162d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-1841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate | 2010-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_484c4043ddedaec00f8b6609100627ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe97fdabbb808fa0e4960f4311b8eaae |
| publicationDate | 2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2010116016-A1 |
| titleOfInvention | Use of peptides of the e1 protein of the hepatitis g virus in order to inhibit the activity of the hiv virus |
| abstract | The invention relates to the use of peptides of the E1 protein of the hepatitis G virus in order to inhibit the activity of the HIV virus. More specifically, the invention relates to the use of at least one peptide, or a derivative of same, contained in the sequence of the E1 protein of the hepatitis G virus (GBV-C/HGV), capable of inhibiting the activity of the HIV virus, impeding or repressing the function and/or activity of the HIV virus (human immunodeficiency virus), in a temporary or permanent manner, or additionally capable of interacting with an amino acid sequence of glycoprotein gp41 of the HIV virus, for the production of a pharmaceutical composition. Said peptide can impede the inhibition of the function of the fragment of protein gp41 of the HIV virus, impede cell fusion or impede the replication of HIV in a host cell. In addition, the invention relates to the aforementioned pharmaceutical composition and to the method for the production thereof. |
| priorityDate | 2009-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.